Skip to content

Evaluation of a Novel Endoscopic Treatment for Achalasia

Evaluation of a Novel Endoscopic Treatment for Achalasia: Per-oral Endoscopic Esophagomyotomy (POEM)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01770249
Acronym
POEM
Enrollment
10
Registered
2013-01-17
Start date
2012-06-30
Completion date
2014-03-31
Last updated
2022-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achalasia

Keywords

dysphagia

Brief summary

This study is to evaluate outcomes of a less invasive surgical procedure for the treatment of achalasia.

Detailed description

This study will assess the feasibility and efficacy of a novel endoscopic procedure, Per-oral Endoscopic Esophagomyotomy (POEM)in treating patients with achalasia.

Interventions

PROCEDUREPer-oral Endoscopic Esophagomyotomy (POEM)

The surgeon is cutting only through the innermost layers of muscles in the esophagus down to the stomach, leaving the outer layer intact.

Sponsors

University Hospitals Cleveland Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* o Subjects with a manometric/radiologic diagnosis of primary achalasia; EGD shows no neoplasm * Ability to undergo general anesthesia * The subject is \> 18 yrs.of age * Ability to give informed consent

Exclusion criteria

* o Sigmoid achalasia * Contraindicated for EGD * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
The success of the POEM procedure is measured by improved symptoms as compared to pre-op, including the ability to swallow with low incidence of GERD and significantly reduced resting LES pressureWithin the first 3 months after surgeryWill assess the outcomes and efficacy of the endoscopic procedure, Per-oral Endoscopic Esophagomyotomy(POEM)in the treatment of achalasia. The patient will be assessed for improvement of their swallowing as assessed on the repeat time barium swallow and increase oral intake without nausea and vomiting.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026